These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Low level ß-lactamase production in methicillin-resistant staphylococcus aureus strains with ß-lactam antibiotics-induced vancomycin resistance. Hirao Y; Ikeda-Dantsuji Y; Matsui H; Yoshida M; Hori S; Sunakawa K; Nakae T; Hanaki H BMC Microbiol; 2012 May; 12():69. PubMed ID: 22568976 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of rapid antimicrobial susceptibility test for Staphylococcus aureus by chemiluminescent assay and its application for screening of beta-lactam antibiotic induced vancomycin-resistant MRSA]. Nagasawa Z; Nakashima Y; Oho M; Kusaba K; Manome I; Nagayama A Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2008; 19(1-2):7-15. PubMed ID: 19583457 [TBL] [Abstract][Full Text] [Related]
12. Exposure of Staphylococcus aureus to subinhibitory concentrations of β-lactam antibiotics induces heterogeneous vancomycin-intermediate Staphylococcus aureus. Roch M; Clair P; Renzoni A; Reverdy ME; Dauwalder O; Bes M; Martra A; Freydière AM; Laurent F; Reix P; Dumitrescu O; Vandenesch F Antimicrob Agents Chemother; 2014 Sep; 58(9):5306-14. PubMed ID: 24957836 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiology and clinical effect against "beta-lactam antibiotic induced vancoymcin-resistant MRSA (BIVR)"]. Hanaki H Jpn J Antibiot; 2004 Apr; 57(2):204-12. PubMed ID: 15219058 [No Abstract] [Full Text] [Related]
14. Identification of the active component that induces vancomycin resistance in MRSA. Ikeda S; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Matsui H; Iwatsuki M; Shiomi K; Nakae T; Sunakawa K; Omura S J Antibiot (Tokyo); 2010 Sep; 63(9):533-8. PubMed ID: 20588304 [TBL] [Abstract][Full Text] [Related]
15. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)]. Hatano K; Yokota Y; Hanaki H; Sunakawa K Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131 [TBL] [Abstract][Full Text] [Related]
16. Improved method of detection of beta-lactam antibiotic-induced VCM-resistant MRSA (BIVR). Hanaki H; Yamaguchi Y; Barata K; Sakai H; Sunakawa K Int J Antimicrob Agents; 2004 Mar; 23(3):311-3. PubMed ID: 15164976 [No Abstract] [Full Text] [Related]
17. Vancomycin and piperacillin-tazobactam against methicillin-resistant Staphylococcus aureus and vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model. Dilworth TJ; Leonard SN; Vilay AM; Mercier RC Clin Ther; 2014 Oct; 36(10):1334-44. PubMed ID: 25066667 [TBL] [Abstract][Full Text] [Related]
18. Rapid depletion of free vancomycin in medium in the presence of beta-lactam antibiotics and growth restoration in Staphylococcus aureus strains with beta-lactam-induced vancomycin resistance. Yanagisawa C; Hanaki H; Matsui H; Ikeda S; Nakae T; Sunakawa K Antimicrob Agents Chemother; 2009 Jan; 53(1):63-8. PubMed ID: 18936187 [TBL] [Abstract][Full Text] [Related]